The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effect of hypertension, and the relationship to the product, if any, cannot be determined.The reported patient effect of hypertension is listed in the xience sierra everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|